Fusicoccin: receptors and endogenous ligands
Aducci, P.; Marra, M.; Ballio, A.
Symposia of the Society for Experimental Biology 44: 111-117
1990
ISSN/ISBN: 0081-1386 PMID: 1966632 Document Number: 350401
Criteria for membrane receptors are outlined and the general characteristics of receptors for fusicoccin (FC), a toxin produced by Fusicoccum [Phomopsis] amygdali, listed. The possible mode of action of FC at the plant plasma membrane and the steps leading to activation of the membrane-bound H+-ATPase (transduction signalling) are considered. The physiological role of the FC receptors is also discussed.
Document emailed within 1 workday
Related Documents
Guidotti, A.; Slobodyansky, E.; Berkovich, A.; Cox, D.H.; Wambebe, C. 1988: The heterogeneity of GABAA receptors and the multiplicity of endogenous ligands for their allosteric modulatory centers Advances in Biochemical Psychopharmacology 45: 219-226Pfeffer, K. 2000: Morphogenic and host protective functions executed by tumor necrosis factor receptors, lymphotoxin receptors and their ligands European Cytokine Network 11(3): 514
Gershtein, E.S.; Bocharova, L.B.; Ermilova, V.D.; Laktionov, K.P.; Kushlinskiĭ 2000: Epidermal growth factor receptors and their ligands in endometrial carcinoma: correlation with clinico-morphologic factors and steroid receptors Voprosy Onkologii 46(2): 180-186
Horváth, G.ön.; Mécs, L.ás.ó 2011: Antinociception by endogenous ligands at peripheral level Ideggyogyaszati Szemle 64(5-6): 193-207
Jaquet, P.; Gunz, G.; Saveanu, A.; Barlier, A.; Dufour, H.; Taylor, J.; Dong, J.; Kim, S.; Moreau, J.P.; Culler, M.D. 2005: BIM-23A760, a chimeric molecule directed towards somatostatin and dopamine receptors, vs universal somatostatin receptors ligands in GH-secreting pituitary adenomas partial responders to octreotide Journal of Endocrinological Investigation 28(11 Suppl International): 21-27
Vartanian, M.E.; Lideman, R.R.; Burbaeva, G.S.; Zozulia, A.A.; Tsutsul'kovskaia, M.I. 1984: Opioid peptides as ligands of neuronal receptors Voprosy Meditsinskoi Khimii 30(3): 73-79
González-Muñiz, R.G.; Domínguez, M.J.; Herranz, R.; García-López, M.T.; Ballaz, S.J.; Fortuño, A.; Del Río, J. 1997: 2,5-Diketopiperidine derivatives as non-peptide ligands for cholecystokinin receptors Farmaco 52(4): 243-246
Herz, A. 1984: The role of multiple opioid receptors and their ligands in pain modulation Arzneimittel-Forschung 34(9a): 1080-1083
Frojmovic, M.; Brown, E.; Kasirer-Friede, A.; Liu, Q. 1996: Limitations and warnings in use of labelled (fibrinogen) ligands to cell receptors Thrombosis and Haemostasis 76(1): 124
Demushkin, V.P.; Kotelevtsev, I.V.; Pliashkevich, I.G.; Khramtsov, N.V. 1982: Probable mechanism of recognition of cholinergic ligands by acetylcholine receptors Molekuliarnaia Biologiia 16(1): 190-200
Dykhno, A.I.; Kostyleva, O.I.; Gershteĭn, E.S.; Polotskiĭ, B.E.; Kushlinskiĭ, N.E. 1998: Epidermal growth factor receptors and their ligands in non-small-cell lung carcinoma Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 5: 51-54
De Lean, A.; Munson, P.J.; Rodbard, D. 1979: Multi-subsite receptors for multivalent ligands. Application to drugs, hormones, and neurotransmitters Molecular Pharmacology 15(1): 60-70
Douglas, S.D. 1978: Alterations in intramembrane particle distribution during interaction of erythrocyte-bound ligands with immunoprotein receptors Journal of Immunology 120(1): 151-157
Naryzhnaia, N.V.; Krylatov, A.V.; Maslov, L.N.; Lishmanov, I.B.; Gross, G.J.; Stephano, J.B. 2001: Role of delta opioid receptors and their ligands in the development of adaptive heart protection against arrhythmogenesis Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova 87(12): 1617-1625
Landen, B.; Strunkheide, K.; Dierich, M.P. 1978: C3-mediated cytoadherence. II. Dependence of cell attachment on similar topographic distribution of the receptors (for C3) and the ligands (C3/C3b) Journal of Immunology 121(6): 2539-2541
Zorin, N.A.; Lykova, O.F.; Konysheva, T.V.; Zorina, V.N. 2006: Specific reactions of polyfunctional proteins of the family of macroglobulins and lactoferrin with receptors and ligands in the protection of the body from pathogens Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 3: 63-67
Gopalakrishnan, M.; Molinari, E.J.; Sullivan, J.P. 1997: Regulation of human alpha4beta2 neuronal nicotinic acetylcholine receptors by cholinergic channel ligands and second messenger pathways Molecular Pharmacology 52(3): 524-534
Herold, F.; Król, M.; Kleps, J. 2004: Synthesis of new hexahydro- and octahydropyrido[1,2-c]pyrimidine derivatives with an arylpiperazine moiety as ligands for 5-HT1A and 5-HT2A receptors. Part IIi Acta Poloniae Pharmaceutica 61(2): 139-150
Cosgaya, J.M.; Aranda, A. 1996: Ras- and Raf-mediated regulation of transforming growth factor beta 1 gene expression by ligands of tyrosine kinase receptors in PC12 cells Oncogene 12(12): 2651-2660
Kosterlitz, H.W. 1987: Endogenous opioids and their receptors Polish Journal of Pharmacology and Pharmacy 39(5): 571-576